Recent Advances in Diagnosis and Treatment of COVID-19
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Diagnostic Microbiology and Infectious Disease".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 4264
Special Issue Editor
Special Issue Information
Dear Colleagues,
As the SARS-CoV-2 pandemic is entering its 3rd year, there is no respite from its adverse impact on global healthcare systems. Even today, there is no effective treatment available. With the new virus mutants emerging every day with increased transmissibility and varying severity, scare of delta-mutant type severe virus is looming large on heads. Therefore, research is required on a fast track to provide more effective and quicker tests to detect viral infection and its mutants with more sensitivity, specificity, cost effectivity, and easy-to-use technology. A better understanding of the virus biology, disease pathogenesis, newer targets for treatment, vaccines effective against pan mutants of the virus, newer drugs or forms of therapies, and repurposing of the older available drugs are being explored or are required to be explored. Similarly, preventive strategies are equally important for the healthcare workers and the general population. Additionally, management of COVID-19 in various specific diseases; autoimmune rheumatic diseases, immunodeficiency disorders, organ transplants (recipients of bone marrow, renal transplant, liver transplant, cardiac and lung transplant), end-stage organ diseases (chronic kidney disease, cirrhosis of liver, pulmonary fibrosis), cardiac disorders including coronary artery disease, pregnancy, pre-, intra- and post-surgical patients, oncology patients, and patients on immunosuppressants requires disease-specific considerations and supportive care. More information is required about such scenarios. It is in this context, Diagnostics invites submissions from eminent researchers/clinicians to submit their novel work (original papers, reviews, and case reports) to the journal for its supplement issue ‘Recent Advances in Diagnosis and Treatment of COVID-19’.
Prof. Dr. Vikas Agarwal
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
